The Revolution is now!
Meet Revo. SPR reimagined for real-world biologics.
Nicoya’s newest Digital SPR platform sets a new standard by combining premium performance with unprecedented accessibility.
Available in 4- and 8-channel configurations, the system brings together years of innovation to deliver best-in-class sensitivity and stability to more scientists than ever before.
With industry-leading low noise and drift, it enables confident analysis of challenging samples and complex applications, unlocking the level of clarity and mechanistic insight traditionally reserved for ultra-premium SPR systems.
Revolutionary features
High-performance data you can trust
Best-in-class sensitivity and stability enable reliable kinetic analysis across peptides, proteins, and complex biologics, with consistent, reproducible results across users and consumable lots.
Efficient, low-touch workflow
The fully automated, cartridge-based system reduces hands-on time by up to 70%, works directly from crude samples without purification or fluidics preparation, and requires only 2 µL per run.
Scalable investment with controlled cost
Expand from four to eight channels without changing workflows, while benefiting from a compact instrument format and cost-effective consumables that lower both upfront and recurring expenses. High-performance data you can trust.
Application highlight
Characterizing small peptide drugs like semaglutide can be demanding with traditional SPR.
In a recent application highlight, Nicoya demonstrated how Revo enables reliable kinetic analysis of semaglutide binding to GLP-1R and HSA using just 2 µL per sample.
With automated in-cartridge dilutions and high sensitivity, Revo delivers robust, low-error data, streamlining peptide characterization in biologics development.
